H&R Block: Could Rebound In 2026 Under New CEO

H&R Block, Inc. trades at 8x earnings with buybacks and a 3.9% yield; learn the upside catalysts, CEO plan, and tax prep ...
Daily Mail

The $71-a-ticket megachurch Christmas show tearing Dallas apart… and the furious fans saying 'Jesus would be flipping tables'

A Christmas show at a church in Plano, Texas, has become a flash point in America - a Rorschach test in today's hyper-political culture. The 'Gift of Christmas' at Prestonwood Baptist Church, as the ...
Forbes

MLB The Show 26 Quietly Teases Sweeping Upgrades Across Multiple Modes

Forbes contributors publish independent expert analyses and insights. Brian Mazique has covered combat sports and video games since 2011. Sony San Diego has revealed new details on gameplay, franchise ...
BioPharma Dive

J&J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma

ORLANDO – A regimen involving Johnson & Johnson’s dual-acting drug Tecvayli could be curative when used early in the disease course of people with multiple myeloma, according to data disclosed Tuesday ...
BioSpace

ASH25: CAR-T Leaders Gilead, J&J Show in Multiple Myeloma; Fulcrum Rises on Sickle Cell Data

The 2025 meeting of the American Society of Hematology features some of the newest developments in blood cancers and rare diseases. The 2025 annual meeting of the American Society of Hematology (2025) ...